1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.01%
Positive revenue growth while OGI.TO is negative. John Neff might see a notable competitive edge here.
-129.16%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-2648.08%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-2648.08%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-1840.05%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-1840.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-1840.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.63%
Share reduction more than 1.5x OGI.TO's 2.56%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.63%
Diluted share reduction more than 1.5x OGI.TO's 2.56%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-163.79%
Negative OCF growth while OGI.TO is at 72.02%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-178.99%
Negative FCF growth while OGI.TO is at 42.02%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
297.40%
5Y revenue/share CAGR 1.25-1.5x OGI.TO's 240.44%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-52.47%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-297.77%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-3403.96%
Negative 5Y OCF/share CAGR while OGI.TO is at 70.62%. Joel Greenblatt would question the firm’s operational model or cost structure.
83.35%
Positive 3Y OCF/share CAGR while OGI.TO is negative. John Neff might see a big short-term edge in operational efficiency.
-51280.40%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-2688.92%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-9959.44%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
6257.60%
10Y equity/share CAGR at 50-75% of OGI.TO's 11693.27%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
29.59%
Positive 5Y equity/share CAGR while OGI.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-12.97%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.67%
Firm’s AR is declining while OGI.TO shows 6.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-15.83%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-20.07%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-24.48%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.85%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
3.64%
R&D growth drastically higher vs. OGI.TO's 3.43%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-11.81%
We cut SG&A while OGI.TO invests at 18.48%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.